6533b7ddfe1ef96bd1275256
RESEARCH PRODUCT
Smartphone-based ecological momentary assessment (EMA) in psychiatric patients and student controls: A real-world feasibility study
Jorge Lopez-castromanPhilippe CourtetJosé H. MarcoSantiago De LeónMaría Luisa BarrigónMaría Sandra Pérez-rodríguezRosa María Molina-madueñoAlejandro Porras-segoviaAntonio Artés-rodríguezSofian BerrouiguetEnrique Baca-garcíaIsaac Díaz-olivánsubject
medicine.medical_specialtyEcological Momentary AssessmentMEDLINEMESH: SmartphoneRisk monitoringAge and sex[INFO.INFO-MC]Computer Science [cs]/Mobile Computing03 medical and health sciences0302 clinical medicineHumansMedicineIn patientSuicidal patientsStudentsPsychiatryMESH: Ecological Momentary AssessmentResponse rate (survey)MESH: Humansbusiness.industryEcology[SCCO.NEUR]Cognitive science/NeuroscienceMobile ApplicationsMental health030227 psychiatryClinical PracticePsychiatry and Mental healthClinical PsychologyMESH: Students[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthFeasibility StudiesSmartphoneMESH: Mobile ApplicationsMESH: Feasibility Studiesbusiness030217 neurology & neurosurgerydescription
Abstract Background Smartphone-based ecological momentary assessment (EMA) is a promising methodology for mental health research. The objective of this study is to determine the feasibility of smartphone-based active and passive EMA in psychiatric outpatients and student controls. Methods Two smartphone applications —MEmind and eB2— were developed for behavioral active and passive monitoring. The applications were tested in psychiatric patients with a history of suicidal thoughts and/or behaviors (STB), psychiatric patients without a history of STB, and student controls. Main outcome was feasibility, measured as response to recruitment, retention, and EMA compliance. Secondary outcomes were patterns of smartphone usage. Results Response rate was 87.3% in patients with a history of STB, 85.1% in patients without a history of STB, and 75.0% in student controls. 457 participants installed the MEmind app (120 patients with a history of STB and 337 controls) and 1,708 installed the eB2 app (139 patients with a history of STB, 1,224 patients with no history of STB and 346 controls). For the MEmind app, participants were followed-up for a median of 49.5, resulting in 22,622 person-days. For the eB2 application, participants were followed-up for a median of 48.9 days, resulting in 83,521 person-days. EMA compliance rate was 65.00% in suicidal patients and 75.21% in student controls. At the end of the follow-up, over 60% of participants remained in the study. Limitations Cases and controls were not matched by age and sex. Cases were patients who were receiving adequate psychopharmacological treatment and attending their appointments, which may result in an overstatement of clinical compliance. Conclusions Smartphone-based active and passive monitoring are feasible methods in psychiatric patients in real-world settings. The development of applications with friendly interfaces and directly useful features can help increase engagement without using incentives. The MEmind and eB2 applications are promising clinical tools that could contribute to the management of mental disorders. In the near future, these applications could serve as risk monitoring devices in the clinical practice.
year | journal | country | edition | language |
---|---|---|---|---|
2020-09-01 | Journal of Affective Disorders |